Risk factors for development of severe hypocalciemia after paratyreoidectomy for secondary hyperparathyroidisis in dialysis patients


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. determination of thethe risk factors for severe hypocalcemia after parathyroidectomy (PTE) for secondary hyperparathyroidism (SHPT) in dialysis-dependent patients. material and methods. The retrospective study included 640 patients who underwent successful pte for shpt. severe hypocalcemia was defined as a blood ionized calcium level of less than o.9 mmol/l on days 2-3 after surgery. results. severe hypocalcemia during the second or third day of the postoperative period was detected in 76.7% of patients. The following factors were associated with the risk of its development: young age (P

Texto integral

Acesso é fechado

Sobre autores

Pavel Kislyy

Saint Petersburg State University Hospital

Email: pashapanda@mail.ru
Leading Specialist in Nephrology of the Clinic, Head of Outpatient Department № 4

Ekaterina Parshina

Saint Petersburg State University Hospital

Email: pannn@yandex.ru
Head of the Department of Nephrology and Dialysis

Aleksey Zulkarnaev

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Email: 7059899@gmail.com
Dr.Sci. (Med.), Associate Professor, Leading Researcher at the Surgical Department of Kidney Transplantation

Aleksey Tolkach

Saint Petersburg State University Hospital

Email: ab2769@mail.ru
Nephrologist at the Department of Nephrology and Dialysis

Svetlana Mikhailova

Saint Petersburg State University Hospital

Email: iamspb@yandex.ru
Nephrologist at the Department of Nephrology and Dialysis

Roman Chernikov

Saint Petersburg State University Hospital

Email: yaddd@yandex.ru
Dr. Sci. (Med.), Head of the Department of Endocrine Surgery

Yana Zarya

«Center of dialysis St. Petersburg»

Email: yana.zarya@fmc-ag.ruinformationabouttheauthors:
Head of the Dialysis Department

Bibliografia

  1. Wang M., Bieber B.A., Karaboyas A., et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin. J. Am. Soc. Nephrol. 2015;10(1):98-109.
  2. Новокшонов К.Ю., Карелина Ю.В., Земченков А.Ю. и др. Результаты скрининга на маркеры минеральных и костных нарушений при хронической болезни почек среди диализных пациентов Северо-Западного Федерального округа. Нефрология. 2016;20(1):36-50.
  3. Nephro.ru (Интернет). Профессиональная организация: Общественная общероссийская организация «Российское диализное общество». Национальные клинические рекомендации: минеральные и костные нарушения при хронической болезни почек. 2015. Доступно по ссылке: http://www.nephro.ru/content/files/recomendations/ckdmbdNationalGuidelines. pdf.
  4. Kestenbaum B., Andress D.L., Schwartz S.M., et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int. 2004;66(5):2010-16.
  5. Costa-Hong V., Jorgetti V., Gowdak L.H.W., et al. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery. 2007;142(5):699-703.
  6. Rudser K.D., de Boer I.H., Dooley A., et al. Fracture risk afterparathyroidectomy among chronic hemodialysis patients. JASN. 2007;18(8):2401-407.
  7. Jain N., Reilly R.F. Hungry bone syndrome. Curr. Opin Nephrol. Hypertens. 2017;26(4):250-55.
  8. Goldfarb M., Gondek S.S., Lim S.M., et al. Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J. Surg. 2012;36(6):1314-19.
  9. Latus J., Roesel M., Fritz P., et al. Incidence of and riskfactors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism. Int. J. Nephrol. Renov. Dis. 2013;6:131-37.
  10. Florescu M.C., Islam K.M., Plumb T.J., et al. Calcium supplementation after parathyroidectomy in dialysis and renal transplant patients. Int. J. Nephrol. Renov. Dis. 2014;7:183-90.
  11. Ge Y., Yang G., Wang N., et al. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int. Urol. Nephrol. 2019;51(8): 1443-49.
  12. Ho L.-Y., Wong P.-N., Sin H.-K., et al. Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC. Nephrol. 2 017;18(1):12.
  13. Torer N., Torun D., Torer N., et al. Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism. Transplant. Proc. 2009;41(9):3642-46.
  14. Mittendorf E.A., Merlino J.I., McHenry C.R. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am. Surg. 2004;70:114-19.
  15. Tan P.G., Ab Hadi I.S., Zahari Z., et al. Predictors of early postoperative hypocalcemia after total parathyroidectomy in renal hyperparathyroidism. Ann. Surg. Treat. Res. 2020;98(1):1-6.
  16. Kritmetapak K., Kongpetch S., Chotmongkol W., et al. Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism. Ren. Fail. 2020;42(1): 1118-26.
  17. Ge Y., Yang G., Wang N., et al. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int. Urol. Nephrol. 2019;51(8): 1443-49. doi: 10.1007/s11255-019-02217-y.
  18. Tsai W.C., Peng Y.S., Chiu Y.L., et al. Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism. Int. Urol. Nephrol. 2015;47(7):1203-207. doi: 10.1007/s11255-015-1016-y.
  19. Xiaoliang S., Xiaoqing Z., Yao L., et al. Risk factors for severe hypocalcemia afterparathyroidectomy in dialysispatients with secondary hyperparathyroidism. Sci. Rep. 2018;8(1):7743. doi: 10.1038/s41598-018-26142-9.
  20. Wang M., Chen B., Zou X. et al. A Nomogram to Predict Hungry Bone Syndrome After Parathyroidectomy in Patients With Secondary Hyperparathyroidism. J. Surg. Res. 2020;255:33-41. doi: 10.1016/j.jss.2020.05.036.
  21. Cavalier E., Eastell R., Jorgensen N.R., et al. IFCC-IOF Committee for Bone Metabolism (C-BM). Correction to: A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I. Collagen (fi-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM). Calcif. Tissue Int. 2021;108(6):825-26. Doi: 10.1007/ s00223-021-00839-y.
  22. Evenepoel P., Cavalier E., D'Haese PC. Biomarkers Predicting Bone Turnover in the Setting of CKD. Curr. Osteopor. Rep. 2017;15(3):178-86. doi: 10.1007/811914-017-0362-3.
  23. Loke S.C., Kanesvaran R., Yahya R., et al. Efficacy of an intravenous calcium gluconate infusion in controlling serum calcium after parathyroidectomy for secondary hyperparathyroidism. Ann. Acad. Med. Singap. 2009;38(12): 1074-80

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies